top of page
Search
BrickBio Achieves Stable Cell Line in Record Timeframe: 5x Faster with 7x Enhanced Production
BOSTON, February 7, 2023 /PRNewswire/ -- BrickBio Highlights Unique Advantages from the Proprietary "VADER" System, published on Dec 22,...
jamesitalia
Feb 8, 20233 min read
BrickBio Unveils Powerful Engineered RNA Therapeutic Modification Platform at AACR 2022
BOSTON, April 25, 2022 /PRNewswire/ -- BrickBio Highlights Powerful Advantage of the Company's BrickADCs™, Protein Origami™, and...
jamesitalia
Apr 25, 20223 min read
BrickBio Announces Rapid V2, eCLIC™, Chemistry and Cytokine External Partner Collaboration
BOSTON, Nov. 2, 2021 /PRNewswire/ -- BrickBio, the leader in site-specific bioconjugation, announced a rapid next-generation conjugation...
jamesitalia
Nov 2, 20212 min read
World's First Antibody Drug Conjugate (ADC) Rapid Predictive SiteSelect™ Panel Launched
BOSTON, Oct. 26, 2021 /PRNewswire/ -- A Rapid Predictive Site-Selection Panel for ADC-Linker-Payload Optimization BrickBio, the leader in...
jamesitalia
Oct 27, 20213 min read
bottom of page